A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression

NCT05268497 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped due to budget decision and wanting to pursue other research priorities

Conditions

Depression

Interventions

DRUG: Esketamine
BEHAVIORAL: Cognitive Behavioral Therapy (CBT)
DRUG: Antidepressant

Sponsor

Janssen Research & Development, LLC